爱康医疗(01789.HK) 发盈喜,预计2024年度股东应占净溢利将较2023年度的1.82亿元增长逾50%。主要由于国家带量采购政策推动下,进一步加速进口替代,带动集团产品的手术量需求持续增长及产品收入增加;及通过实施有效成本控制手段,经营成本及行政开支相对稳定。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-07 16:25。)
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2024/08/28 | 中期业绩 | 无派息 |
2024/03/26 | 末期业绩 | 股息:港元 0.0450 |
2023/08/22 | 中期业绩 | 无派息 |
2023/03/27 | 末期业绩 | 股息:港元 0.0600 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.